Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability and Food Effect of Danicopan Formulations
NCT04609696Phase 1Completed
- Sponsor
- Alexion Pharmaceuticals
- Start
- Oct 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of danicopan in paroxysmal nocturnal hemoglobinuria (PNH) (6 arms), sponsored by Alexion Pharmaceuticals. Primary endpoints: Relative Bioavailability Of Danicopan Prototype PIC 1 Formulation And Tablet Formulation, AUC0-inf Of Danicopan Prototype PIC 1 Formulation Under Both Fed And Fasted Conditions and 8 more. Started Oct 2020; status: completed.
02
Drugs
danicopan
03
Conditions
paroxysmal nocturnal hemoglobinuria (PNH)
Beyond the preview
Go deeper on NCT04609696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04609696.